DSM invests in biomaterials company Oxford Performance Materials

22-Jun-2006

DSM Venturing, the corporate venturing unit of Royal DSM N.V., announced that it has invested $ 1.2 mln in the biomaterials company Oxford Performance Materials (OPM). This investment links on to DSM's innovation ambitions in the emerging business area (EBA) of biomedical materials, which is an important element of DSM's strategy Vision 2010 - Building on Strengths.

OPM markets biocompatible high performance polymers for use in medical device applications such as catheters and implantable devices. OPM's polymers offer advantages over metals in terms of improved biocompatibility, process flexibility, radiolucense and tailored formulations to meet biomechanical and design criteria.

Other news from the department business & finance

These products might interest you

Eclipse

Eclipse by Wyatt Technology

FFF-MALS system for separation and characterization of macromolecules and nanoparticles

The latest and most innovative FFF system designed for highest usability, robustness and data quality

Spinsolve Benchtop NMR

Spinsolve Benchtop NMR by Magritek

Spinsolve Benchtop NMR

Spinsolve is a revolutionary multinuclear NMR spectrometer that provides the best performance

HYPERION II

HYPERION II by Bruker

FT-IR and IR laser imaging (QCL) microscope for research and development

Analyze macroscopic samples with microscopic resolution (5 µm) in seconds

FT-IR microscopes
Loading...

More news from our other portals

All FT-IR spectrometer manufacturers at a glance